Comparison of Aspheric Toric Intraocular Lenses for Micro-monovision
Launched by GUY'S AND ST THOMAS' NHS FOUNDATION TRUST · Aug 16, 2022
Trial Information
Current as of August 25, 2025
Unknown status
Keywords
ClinConnect Summary
Cataract is a condition caused by progressive clouding of the natural crystalline lens inside the eye. This leads to impairment of visual performance. This condition represents a huge disease burden and is a leading cause of reversible blindness worldwide. In the UK and the developed world, the incidence of cataract induced blindness continues to increase, secondary to an aging population and increasingly common risk factors such as diabetes. In 1950, Harold Ridley inserted an intraocular lens following cataract extraction at St Thomas' Hospital. This was the first recorded surgery of its k...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Bilateral cataract requiring surgical intervention,
- • age over 18 years
- • able to understand informed consent and the objectives of the trial,
- • not pregnant, not breast feeding
- • no previous intraocular eye surgery
- • good visual potential in both eyes
- • corneal astigmatism of 1.5 to 6 dioptres
- Exclusion Criteria:
- * Any patient with other ocular condition that might reduce visual acuity and hence confound the results such as:
- • visually impairing age-related macular degeneration
- • Advanced glaucoma
- • previous retinal vascular disorders
- • previous retinal detachment or tear
- • any visually impairing neuro-ophthalmological condition
- • any inherited retinal disorder or pathology
- • previous strabismus surgery or record of amblyopia
- • previous visually impairing CVA, TIA or other vaso-occlusive disease
- • already enrolled in another study or trial
- • instability of keratometry or biometry measurements
- • irregular astigmatism
- • previous significant trauma to eye
About Guy's And St Thomas' Nhs Foundation Trust
Guy's and St Thomas' NHS Foundation Trust is a leading healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality patient care, innovative research, and clinical excellence. As a prominent academic health science center, the Trust integrates cutting-edge research with clinical practice, facilitating the translation of scientific discoveries into improved treatment options. With a diverse portfolio of clinical trials across various medical specialties, Guy's and St Thomas' NHS Foundation Trust plays a pivotal role in advancing healthcare knowledge and enhancing patient outcomes, while maintaining the highest ethical standards in research and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
David O'Brart, MBBS, MD
Study Director
Guy's and St Thomas' NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials